Antineo is a privately-owned Contract Research Organisation founded in 2015. We provide preclinical expertise and services to private companies and academic institutions in the field of Oncology.
Located in Lyon Est Bio-Health campus and working in close partnership with the Cancer Research Center of Lyon, Antineo offers an exceptional environment for translational research in onco-pharmacology.
3 ongoing partnerships
Our goal is to accelerate and optimize the development of new anticancer agents and to support our clients in a go-fast decision and in a cost-effective manner. To achieve it, we provide research services and expertise in vitro, ex vivo and in vivo oncology.
We explore the characteristics and effects of your compounds using cutting-edge technologies and our extensive bank of preclinical human and murine tumour models.
Our team and scientific committee are composed of scientists, oncologists and haematologists with international level expertise in onco-pharmacology, providing a strategic vision for short and medium-term development strategies.
Our scientific expertise and our operational reactivity are dedicated to the success of your development.